Marcello Mignogna
Lucca, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Mixed endometrial carcinoma: is it time to profile the two components separately?
Journal: Frontiers in oncology
Published: October 30, 2025
The Evolving Landscape of Novel and Old Biomarkers in Localized High-Risk Prostate Cancer: State of the Art, Clinical Utility, and Limitations Toward Precision Oncology.
Journal: Journal of personalized medicine
Published: July 04, 2025
AIRO Breast Cancer Group Best Clinical Practice 2022 Update.
Journal: Tumori
Published: September 16, 2022
MRI apparent diffusion coefficient (ADC): A biomarker for prostate cancer after radiation therapy.
Journal: Turkish journal of urology
Published: February 04, 2022
Stereotactic radiotherapy for bone oligometastases.
Journal: Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
Published: August 17, 2021
COVID-19 safe and fully operational radiotherapy: An AIRO survey depicting the Italian landscape at the dawn of phase 2.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: August 28, 2020
COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: April 27, 2020
Practical indications for management of patients candidate to Interventional and Intraoperative Radiotherapy (Brachytherapy, IORT) during COVID-19 pandemic - A document endorsed by AIRO (Italian Association of Radiotherapy and Clinical Oncology) Interventional Radiotherapy Working Group.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: April 16, 2020
Prostate-specific antigen percentage: An early predictive tool after iodine-125 interstitial brachytherapy for prostate cancer.
Journal: Brachytherapy
Published: February 11, 2017
Low dose rate brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy: practice and outcome analysis in a series of 2237 patients from 11 institutions.
Journal: The British journal of radiology
Published: July 08, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026